Clinics On Cloud, the Pune-based maker of AI-driven health ATMs, has raised Rs 120 crore (about $12.5 million) in a Series A round from Model42, the medtech investment arm of Dubai-based Enlightened Minds Investments. The round values the company at Rs 600 crore, or roughly $63.3 million. Inc42 reported it on the evening of 2 November, and BusinessLine carried the same figures hours later.
This is the first institutional cheque the company has taken since Abhay Agarwal and Manashrri Agarwal founded it in 2018. Rs 120 crore of fresh money against a Rs 600 crore post-money mark works out to roughly a fifth of the company sold, putting the pre-money value near Rs 480 crore.
Read more on newzshort:
CureBay Raises Rs 100 Crore Pre-Series C To Grow Rural Clinics From 250 To 800
What The Money Is For
In a statement, the company said the capital will fund AI-led clinical capability, research and development, the wider micro-clinic ecosystem, manufacturing capacity and partnerships with hospitals and government health programmes. It also intends to use the UAE as a base for international expansion, naming Africa, the United States and Southeast Asia as target markets.
Agarwal framed the round around access rather than scale. Quality healthcare should never depend on someone’s PIN code, he said in the statement, adding that the money gives the company room to take that idea into markets outside India. The pitch is not a new app but physical hardware, placed where a pathology lab would never open a branch.
Read more on newzshort:
Confido Health Raises $12.5 Million to Automate Healthcare Administration With AI
Eight Years Without A Cheque
The company started in a two-bedroom apartment in 2018 and spent its first two years building prototypes that were tested at health camps rather than sold. A first office followed only in 2020, when the earliest machines reached hospitals. A partnership with a public sector enterprise in 2021 and 2022 widened assembly work and pushed the units into state health programmes, and the company set up its own factory at Chakan near Pune in 2023 and 2024, then a second facility in 2025.
The Numbers Behind The Network
Clinics On Cloud says it has more than 3,500 deployments across 200 Indian cities and seven other countries, and that its machines have screened more than 1.2 crore patients. The hardware is built to read about 65 clinical parameters, from blood pressure and SpO2 to haemoglobin and HbA1c, in a claimed ten-minute cycle. The range has widened from the original kiosk to portable box clinics, health lounges and mobile medical units, and the company’s own Clinics On Cloud site puts live operations in more than eight countries. It also describes itself as profitable and debt free, a claim not backed by published accounts.
Why The Valuation Is Hard To Test
Neither the company nor Model42 has disclosed revenue, so the Rs 600 crore mark has no multiple attached to check it against. Ultrahuman, the Bengaluru smart ring maker, raised $70 million in September, more than this company’s entire valuation, while CARPL.ai took $10 million in July. Inc42 puts the Indian healthtech opportunity at $37 billion by 2030, a forecast broad enough to flatter almost any plan.
The model is also capital hungry in a way that software is not. Every health ATM is a machine that must be manufactured, shipped, serviced and recalibrated, and its life is spent in district hospitals and rural camps rather than a data centre. Much of the demand sits with government programmes, where tender cycles run long and payments arrive late.
Risks And Open Questions
Two questions matter more than the headline number. The first is regulatory: screening equipment sold as wellness infrastructure has to keep its claims inside device rules that differ by market, and a ten-minute full checkup invites exactly that scrutiny as the company moves abroad. The second is whether the Gulf hub becomes a rollout or only a holding structure. The UAE plan, as announced, is an intention rather than an installation list.
The editorial read: this is a strong round for a company that built hardware for eight years without venture money, and the discipline shows in the factory and the government roster. But a fifth of the company sold at $63 million, with no revenue on the table, prices execution rather than proven unit economics. The next year should be judged on deployments outside India, not on the size of the cheque.
What To Watch
Watch the deployment count, which must move past 3,500 for the global story to carry weight, and the use of the second Chakan line. Watch too whether the first overseas installation lands in Africa or Southeast Asia, and whether the company begins publishing revenue as it courts further capital.
